Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 19;15(10):e47324.
doi: 10.7759/cureus.47324. eCollection 2023 Oct.

Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features

Oktay Ünsal  1 , Büşra Güvercin  2 , Ahmet Özet  1 , Mehmet Ali Ergün  3
Affiliations

Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features

Oktay Ünsal et al. Cureus. .

Abstract

Objective: The ATM gene is one of the most common breast cancer (BC) susceptibility genes after BRCA1/2 and has been shown to be a moderate BC susceptibility gene. The association between ATM germline mutation and clinical features of BC is now unknown. In this article, clinicopathological features of BC patients with ATM germline heterozygous mutation were investigated.

Materials and methods: Patients admitted to the Medical Genetics department of a tertiary hospital between January 2020 and December 2022 were examined. Only invasive BC patients with pathogenic mutation, likely pathogenic mutation, or variants of uncertain significance (VUS) were included in the study.

Results: In all, 121 patients were included in the study. The median age at the first cancer diagnosis of the patients was 44 years. Of the total number of patients, 75.2% (91) had the histological subtype of infiltrating ductal carcinoma, and 43% (52) had Luminal B molecular subtype features. At a median follow-up of 16 months, 5.8% (7) of patients developed cancer in the contralateral breast. In addition, 7.4% (9) of the patients developed a second primary cancer during follow-up. When the patients were compared according to ATM variant classification, the localization, histologic types, and molecular subtypes of the BC were not different between all groups (respectively; p=0.68, p=0.65, p=0.32).

Conclusions: To the best of our knowledge, this is the first publication that evaluates the clinical and pathological characteristics of BC patients with germline heterozygous ATM mutations in the Turkish population. When patients were compared according to variant classifications of ATM mutation, patients' histological and molecular subtypes were similar.

Keywords: atm; breast cancer; germline mutation; heterozygous; turkish population.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer. Kapoor NS, Curcio LD, Blakemore CA, Bremner AK, McFarland RE, West JG, Banks KC. Ann Surg Oncol. 2015;22:3282–3288. - PubMed
    1. DNA replication stress as a hallmark of cancer. Macheret M, Halazonetis TD. Annu Rev Pathol. 2015;10:425–448. - PubMed
    1. Hallmarks of cancer: the next generation. Hanahan D, Weinberg RA. Cell. 2011;144:646–674. - PubMed
    1. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Lavin MF. Nat Rev Mol Cell Biol. 2008;9:759–769. - PubMed
    1. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Shiloh Y, Ziv Y. https://www.nature.com/articles/nrm3546#citeas Nat Rev Mol Cell Biol. 2013;14:197–210. - PubMed

LinkOut - more resources